|
Codex Dna Inc
DNAY's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Codex Dna Inc growth rates, revenue grew
by 32.19 % in I. Quarter 2023 from the same quarter a year ago.
Ranking at No. 1012
Laboratory Analytical Instruments industry recorded
growth of revenues by 3.56 %
Codex Dna Inc net loss decreased from $-13 millions, to $-11 millions in I. Quarter 2023,
• More on DNAY's Growth
|
|
Codex Dna Inc realized a net loss in trailing twelve months.
Codex Dna Inc realized cash reduction of $ -0.26 per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.86.
• More on DNAY's Valuation
|
|
|
|
|
Codex Dna Inc realized net loss in trailing twelve months.
Codex Dna Inc realized cash outflow of $ -0.26per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.86.
• More on DNAY's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com